Department of Nephrology, Faculty of Medicine, Saitama Medical University, 38 Morohongo, Moroyama-machi, Iruma-gun, Saitama, 350-0495, Japan.
Department of General Internal Medicine, Faculty of Medicine, Saitama Medical University, 38 Morohongo, Moroyama-machi, Iruma-gun, Saitama, 350-0495, Japan.
Biochem Biophys Res Commun. 2019 Sep 10;517(1):96-102. doi: 10.1016/j.bbrc.2019.07.024. Epub 2019 Jul 15.
Here we evaluated the efficacy of depleting cellular communication network factor 2 (CCN2) produced by renal tubular epithelial cells in preventing the progression of severe acute kidney injury (AKI) to chronic kidney disease (CKD). We used conditional Ccn2 knockout mice in which expression of Ccn2 was controlled by γ-glutamyl transpeptidase promoter-regulated Cre recombinase. AKI was induced by ischemia-reperfusion injury. An effect of inhibiting Ccn2 expression by tubular epithelial cells on acute damage, assessed according to the levels of kidney injury molecule-1, was not detected 3 days after injury. However, by day 14, interstitial fibrosis and the levels of the extracellular matrix and profibrotic cytokines were reduced in Ccn2 knockout mice compared with wild-type mice. The ectopic expression of the pan-caspase inhibitor p35 reduced the number of apoptotic cells in damaged tubular epithelial cells 3 days after ischemia-reperfusion injury. In contrast, interstitial fibrosis was exacerbated, accompanied by increased levels of transforming growth factor-β and plasminogen-activator inhibitor-1 14 days after insult. Depletion of CCN2 from tubular epithelial cells slowed the progression of interstitial fibrosis, which was promoted by ectopic expression of p35 in the same cells. These results indicate that tubular epithelial cells, which should be eliminated by apoptosis during physiological repair of AKI, produced CCN2 in the damaged kidney and that CCN2 expression in damaged tubular epithelial cells made a critical contribution to the transition from AKI to CKD. Moreover, inhibiting CCN2 expression may represent a therapeutic approach for preventing the progression of AKI to CKD, irrespective of the stage of kidney disease.
在这里,我们评估了通过耗尽肾脏管状上皮细胞产生的细胞通讯网络因子 2 (CCN2) 来预防严重急性肾损伤 (AKI) 向慢性肾脏病 (CKD) 进展的疗效。我们使用了条件性 Ccn2 敲除小鼠,其中 Ccn2 的表达受γ-谷氨酰转肽酶启动子调控的 Cre 重组酶控制。AKI 是通过缺血再灌注损伤诱导的。在损伤后 3 天,未检测到管状上皮细胞抑制 Ccn2 表达对急性损伤的影响,根据肾损伤分子-1 的水平评估。然而,到第 14 天,与野生型小鼠相比,CCN2 敲除小鼠的间质纤维化和细胞外基质及促纤维化细胞因子水平降低。泛半胱天冬酶抑制剂 p35 的异位表达减少了缺血再灌注损伤后 3 天受损管状上皮细胞中的凋亡细胞数量。相比之下,14 天后,间质纤维化加剧,伴随着转化生长因子-β和纤溶酶原激活物抑制剂-1 水平的升高。管状上皮细胞中 CCN2 的耗竭减缓了间质纤维化的进展,而 p35 在同一细胞中的异位表达促进了间质纤维化的进展。这些结果表明,在 AKI 的生理修复过程中应该通过细胞凋亡消除的管状上皮细胞在受损肾脏中产生了 CCN2,并且受损管状上皮细胞中的 CCN2 表达对从 AKI 向 CKD 的转变做出了关键贡献。此外,抑制 CCN2 的表达可能代表了一种预防 AKI 向 CKD 进展的治疗方法,而与肾脏病的阶段无关。